rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Granules India Ltd.

532482 GRANULES Group (A)

16 Jul,15:29
519.50
-0.65 (-0.12%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Granules India Ltd.

BUYSELL

33,868 520.15 522.95 - 517.25 498.85 - 283.10 12,592.68
NSE | BSE

Granules India Ltd.

GRANULES

16 Jul,15:51
520.85
0.70 (0.13%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Granules India Ltd.

BUYSELL

475,628 520.15 523.00 - 517.20 530.65 - 287.70 247,607,180.52

News for Granules India Ltd.

India-UAE Trade...
India-UAE Trade Pact: GTRI Raises Concerns Over Precious Metal Imports
GTRI expresses concerns about increased precious metal imports from UAE under the India-UAE CEPA, highlighting potential revenue loss and impact on domestic jewellery industry.
Jul 16, 2024 14:58
Lupin Sells...
Lupin Sells Women's Health Business to Evofem for $84 Million
Lupin has divested its US-based women's health speciality business to Evofem Biosciences for up to $84 million. The deal includes the commercialization of Solosec, an FDA-approved treatment for...
Jul 15, 2024 19:54
Granules India Promoter Sells 3.09% Stake for Rs 304 Crore
Krishna Prasad Chigurupati, promoter of Granules India, sold 3.09% stake for Rs 304 crore via open market transaction, reducing his holding to 31.69%.
May 22, 2024 19:13
Granules India Q4 Profit Up 8% to Rs 130 Cr
Granules India's Q4 profit rose 8% to Rs 130 crore, while revenue declined. The company's full-year profit was down 22%. Read more about the financial results and future outlook.
May 15, 2024 17:00
Granules India Gets USFDA Approval for Generic Gout Medication
Granules India receives USFDA approval to market Colchicine Capsules (0.6 mg) for gout prevention and treatment. The generic medication is therapeutically equivalent to Hikma International...
Apr 30, 2024 11:31

More News for Granules India Ltd. »

(Rs. Crore)

Financial Results of Granules India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,755.093,931.203,238.443,134.982,309.93
Operating profit801.36838.24644.65861.37494.14
Interest72.0038.6716.3523.7726.86
Gross profit735.14809.50645.81851.32493.73
EPS (Rs)17.9920.6115.5822.3217.47

See more in Research Center »

About Granules India Ltd.

Granules India Limited is an Indian multinational pharmaceutical manufacturing company based in Hyderabad. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. Granules India Limited also operates in the contract research and manufacturing (CRAM) segment. Wikipedia

News for Pharmaceuticals and health care

Ripley & Co to...
Ripley & Co to Modernize Haldia Berth with Rs 600cr Investment
Ripley & Co and Bothra Shipping Services will invest Rs 600 crore to automate and modernize Berth No. 5 at Haldia Dock Complex, boosting cargo handling capacity to 5 million tonnes.
Jul 16, 2024 22:59
India To Set Up...
India To Set Up Centre For Trade Negotiation Skills
India's Commerce Ministry plans to establish a centre for negotiation skills to enhance expertise in FTAs and business deals, aimed at boosting trade and improving IIFT rankings.
Jul 16, 2024 22:07
SBI 444-Day Term...
SBI 444-Day Term Deposit: Up to 7.25% Annual Returns
State Bank of India launches a 444-day term deposit offering up to 7.25% annual returns. This comes amid growing differences in credit and deposit growth within the banking system.
Jul 16, 2024 22:07
Vi Improves...
Vi Improves Network Coverage in Uttarakhand & UP
Vi expands L900 & L2100 technologies in UP and Uttarakhand, offering improved indoor coverage and faster data speeds for users.
Jul 16, 2024 21:59
Swiss Investment...
Swiss Investment in India: Goyal Invites Firms
India's Commerce Minister Piyush Goyal has invited Swiss companies to invest in India, highlighting the potential of various sectors. The visit focused on implementing the India-EFTA Trade and...
Jul 16, 2024 21:55

More News »

Top News

Elon Musk Moves...
Elon Musk Moves SpaceX, X HQ to Texas: California Law the 'Final Straw'
Elon Musk is moving SpaceX and X headquarters to Texas from California, citing a new law barring schools from notifying parents of gender identity changes as the 'final straw'.
Jul 17, 2024 01:42
NITI Aayog...
NITI Aayog Reconstituted: 15 Ministers, NDA Allies Included
The NITI Aayog has been reconstituted with 15 union ministers, including those from NDA allies, as members. Prime Minister Modi remains chairman, while economist Suman K Bery continues as...
Jul 16, 2024 23:35
Ripley & Co to...
Ripley & Co to Modernize Haldia Berth with Rs 600cr Investment
Ripley & Co and Bothra Shipping Services will invest Rs 600 crore to automate and modernize Berth No. 5 at Haldia Dock Complex, boosting cargo handling capacity to 5 million tonnes.
Jul 16, 2024 22:59
Niti Aayog...
Niti Aayog Reconstituted: New Members Added
The Narendra Modi government has reconstituted Niti Aayog, adding new members including Shivraj Singh Chouhan, Jagat Prakash Nadda and HD Kumaraswamy. Learn more about the changes.
Jul 16, 2024 22:34
India To Set Up...
India To Set Up Centre For Trade Negotiation Skills
India's Commerce Ministry plans to establish a centre for negotiation skills to enhance expertise in FTAs and business deals, aimed at boosting trade and improving IIFT rankings.
Jul 16, 2024 22:07

More Top News »

Report Card

PE Ratios
28.88
EPS (Rs.)
17.99
Sales (Rs. Cr)
940.19
Face Value (Rs.)
1
Net Profit Margin (%)
12.68
Last Bonus
Last Dividend(%)
150
Return on Average Equity
18.56

Compare 'Granules India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,585.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,575.35
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,187.90
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,792.80
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 2,951.25
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,442.75
  • Compare
  • Max Healthcare Institute Ltd.
  • 920.90
  • Compare
  • Alkem Laboratories Ltd.
  • 5,383.05
  • Compare

Most Active

  • Change (Rs.)
  •  

Granules India Ltd. performance snapshot

If you had invested Rs.  in Granules India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Granules India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Granules India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close